Activation of tyrosine kinase c-Abl contributes to α-synuclein–induced neurodegeneration-Reference-Cited by-同舟云学术

Activation of tyrosine kinase c-Abl contributes to α-synuclein–induced neurodegeneration

Published:2016-06-27 Issue:8 Volume:126 Page:2970-2988
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Brahmachari Saurav,Ge Preston,Lee Su Hyun,Kim Donghoon,Karuppagounder Senthilkumar S.,Kumar Manoj,Mao Xiaobo,Shin Joo Ho,Lee Yunjong,Pletnikova Olga,Troncoso Juan C.,Dawson Valina L.,Dawson Ted M.,Ko Han Seok

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference63 articles.

1. Diagnosis and treatment of Parkinson disease: molecules to medicine

2. Parkinson's Disease

3. Nonmotor symptoms in Parkinson’s disease in 2012: relevant clinical aspects;Bonnet;Parkinsons Dis,2012

4. Alpha-synuclein and neurodegenerative diseases

5. 100 years of Lewy pathology;Goedert;Nat Rev Neurol,2013

Cited by 130 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The identification of c-Abl inhibitors as potential agents for Parkinson’s disease: a preliminary in silico approach;Molecular Diversity;2024-01-25

2. A Phase I, Randomized, SAD, MAD, and PK Study of Risvodetinib in Older Adults and Parkinson’s Disease;Journal of Parkinson's Disease;2024-01-13

3. Advancements in Genetic and Biochemical Insights: Unraveling the Etiopathogenesis of Neurodegeneration in Parkinson’s Disease;Biomolecules;2024-01-05

4. Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases;npj Parkinson's Disease;2023-12-07

5. Discovery of conformationally constrained c-Abl inhibitors with potential neuroprotective effects against Parkinson’s disease;Bioorganic & Medicinal Chemistry;2023-12